Bresmed Health Solutions Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2005Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
−£201,361
Cash
£815,978
Turnover
£19,467,423
Profit / loss
−£434,251
Current assets
£7,616,394
Creditors < 1 year
£7,111,904
Equity
−£201,361
Average employees
77
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read | 2020-03-3112 months | 2019-03-3112 months | 2011-01-31 | 2010-01-31 |
|---|---|---|---|---|---|---|
| Balance sheet | ||||||
| Net assets | −£201,361 | £242,332 | −£994,823 | £97,655 | £95,895 | £4,368 |
| Equity | −£201,361 | £242,332 | −£994,823 | £97,655 | £95,895 | £4,368 |
| Share capital | £1,000 | £1,000 | — | — | — | — |
| Retained earnings | −£1,863,182 | −£1,428,931 | — | — | — | — |
| Assets | ||||||
| Fixed assets | £278,834 | £1,160,157 | £751,874 | £834,484 | £9,511 | £2,544 |
| Intangible assets | — | £83,494 | — | — | — | — |
| Property, plant & equipment | £265,524 | £1,063,353 | £738,564 | £821,174 | £9,511 | £2,544 |
| Investments | £13,310 | £13,310 | — | — | — | — |
| Current assets | £7,616,394 | £9,622,417 | £3,387,938 | £3,666,186 | £211,431 | £44,742 |
| Cash at bank | £815,978 | £1,669,841 | £209,759 | £200,817 | £48,465 | £6,855 |
| Debtors | £6,800,416 | £7,952,576 | £3,178,179 | £3,465,369 | £162,966 | £37,887 |
| Liabilities | ||||||
| Creditors within one year | £7,111,904 | £9,896,730 | £4,944,013 | £3,736,256 | — | — |
| Creditors after one year | £395,685 | £643,512 | £109,522 | £570,834 | — | — |
| Provisions | £589,000 | — | £81,100 | £95,925 | — | — |
| Net current assets | £504,490 | −£274,313 | −£1,556,075 | −£70,070 | £86,384 | £1,824 |
| Assets less current liabilities | — | — | −£804,201 | £764,414 | £95,895 | £4,368 |
| Profit & loss | ||||||
| Turnover | £19,467,423 | £19,370,692 | — | — | — | — |
| Cost of sales | £10,132,839 | £11,027,749 | — | — | — | — |
| Gross profit | £9,334,584 | £8,342,943 | — | — | — | — |
| Administrative expenses | £10,599,238 | £8,600,998 | — | — | — | — |
| Operating profit | −£1,264,654 | −£258,055 | — | — | — | — |
| Interest receivable | £131,650 | — | — | — | — | — |
| Interest payable | £65,637 | £79,548 | — | — | — | — |
| Profit before tax | −£673,693 | −£337,603 | — | — | — | — |
| Tax | −£239,442 | −£80,419 | — | — | — | — |
| Profit / loss | −£434,251 | −£257,184 | −£1,092,478 | £11,007 | — | — |
| Operating costs | ||||||
| Depreciation | £509,640 | £307,924 | — | — | — | — |
| People & pay | ||||||
| Average employees | 77 | 67 | 88 | 85 | — | — |
| Staff costs | £6,884,930 | £5,590,278 | — | — | — | — |
| Wages & salaries | £5,770,514 | £4,686,945 | — | — | — | — |
| Social security costs | £732,935 | £511,606 | — | — | — | — |
| Pension costs | £390,923 | £375,130 | — | — | — | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Principal activity
- The principal activity of the Company continued to be that of research and experimental development on biotechnology
- What it does
- research · experimental development · biotechnology (AI keywords)
- The year
- During the year, the Company reported gross profit of £9,334,584 (2024 £8,342,943). This increase was as a result of reduction in third-party project costs. The Company had an operating loss of £1,264,654 (2024 loss £258,055).
- Outlook
- The Company will continue to operate in this sector for the foreseeable future
- Audit
- Subsidiary audit exemption, parent guarantee (s479A)
- Immediate parent
- Bresmed Holdings Limited · United Kingdom
- Ultimate parent
- Value Demonstration Group Holdings, LLC · United States
- Ultimate controlling party
- Value Demonstration Group Holdings, LLC
- Accounts
- FRS 101
- Approved
- 2026-07-16
Subsidiaries (3)
- Bresmed Health Solutions India Limited · 100% · Emaar Capital Tower 1, Unit No 701 & 702, Mehrauli-Gurgaon Road, Sikanderpur, Sector 26, Gurugram, HR 122002 India
- Bresmed Ireland Limited · 100% · C/O Fitzgerald Power, Greyfriars, Waterford, Ireland
- Bresmed Netherlands BV · 100% · Van Deventerlaan 30, 3528 AE Utrecht, The Netherlands
Turnover by segment (6)
- United Kingdom: 4,762,710 (2025-12-31)
- Rest of Europe: 2,899,927 (2025-12-31)
- USA: 11,804,786 (2025-12-31)
- United Kingdom: 3,590,267 (2024-12-31)
- Rest of Europe: 3,120,783 (2024-12-31)
- USA: 12,659,642 (2024-12-31)
Related parties (3)
- Bresmed Netherlands B V · subsidiary undertaking · Dividend income · 524,948
- group companies · group companies · Interest receivable · 131,650
- group undertakings · group undertakings · Amounts owed by group undertakings · 521,627
Share classes (3)
- 85,000 Ordinary of 1p
- 15,000 Ordinary A of 1p
- 1 Ordinary of 1p
Principal risks (4)
- Client Relationships
- Macroeconomic uncertainty
- Key staff
- Supplier Relationships
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFloating · created 2021-01-27
—
OutstandingShow 4 satisfied / released
All Assets · created 2017-12-27 · satisfied 2020-04-24
—
SatisfiedAll Assets · created 2014-09-30 · satisfied 2021-01-20
—
SatisfiedAll Assets · created 2014-09-30 · satisfied 2021-01-20
—
SatisfiedFloating · created 2009-04-09 · satisfied 2014-09-18
All monies
Satisfied